Peer Review in Ophthalmology and the Council of Vision Editors Fellow Program

Peer Review in Ophthalmology and the Council ...

AMERICAN ACADEMY OF OPHTHALMOLOGYAMERICAN ACADEMY OF OPHTHALMOLOGY

Up next

Hydrus Microstent Clinical Outcomes for Open-Angle Glaucoma

Dr. Thomas Johnson returns to the podcast. Dr. Emily Schehlein interviews him on his study to assess the clinical outcomes of Hydrus Microstent implantation with cataract extraction for the treatment of open-angle glaucoma. From the Ophthalmology Glaucoma article, Clinical Outcom ...  Show more

 . 17min 51sec
ChatGPT-4o Responses to Patient Questions

How accurate is ChatGPT responding to patient questions at a 6th grade reading level vs. a 12th grade reading level? Find out in this episode as Drs. Rukhsana Mirza and Angelo Tanna discuss their Ophthalmology Science article, "Accuracy and Readability of Chat Generative Pre-Trai ...  Show more

 . 18min 51sec

Recommended Episodes

#192 Debate on First-Line Medications for Diabetes
Core IM | Internal Medicine Podcast

SGLT-2i vs. GLP-1? vs Metformin? How do you balance the cost and coverage of first-line options like metformin, SGLT-2, and GLP-1s? How do you choose between SGLT-2 and GLP-1s for comorbidities like CAD or CKD? And how do you weigh their side effects and practical use?🔹 Sponsor: ...  Show more

 . 36min 50sec
#337 - Insulin resistance masterclass: The full body impact of metabolic dysfunction and prevention, diagnosis, and treatment | Ralph DeFronzo, M.D.
The Peter Attia Drive

View the Show Notes Page for This Episode

<a href= "https://peterattiamd.com/subscribe/ ...

  Show more

 . 2h 26min
S3 Episode 2: Treating Type 2 Diabetes in an Aging Population: Geriatric Syndromes, Comorbidities, and Treatment De-escalation
Medscape InDiscussion: Type 2 Diabetes

Drs Carol H. Wysham and Medha Munshi discuss type 2 diabetes in older adults, understanding geriatric syndromes and how they impact care, and when to de-escalate treatment. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarti ...  Show more

 . 22min 45sec
Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes
Annals On Call Podcast

Dr. Centor discusses outcomes in patients with type 2 diabetes when treated with semaglutide or dulaglutide versus empagliflozin with Drs. Kevin Kip and Anum Saeed. 

 . 29min 55sec